Agilent Technologies discusses the incorporation of targeted single-cell multi-omics to complement their product portfolio

Kevin Corcoran, Vice President of Agilent Technologies, discusses the incorporation of targeted single-cell multi-omics to complement Agilent's product portfolio and provide a more comprehensive oncology offering. He hosts Aaron Llanso of Mission Bio, who presents case studies on the use of single-cell sequencing in hematology, solid tumors, and gene editing.